BIFULCO, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 7.244
EU - Europa 2.436
AS - Asia 2.261
SA - Sud America 193
OC - Oceania 9
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.158
Nazione #
US - Stati Uniti d'America 7.213
CN - Cina 772
SG - Singapore 650
UA - Ucraina 616
IT - Italia 486
VN - Vietnam 425
RU - Federazione Russa 391
DE - Germania 260
SE - Svezia 212
IE - Irlanda 206
BR - Brasile 175
TR - Turchia 175
FI - Finlandia 149
KR - Corea 97
HK - Hong Kong 65
IN - India 37
GB - Regno Unito 29
CZ - Repubblica Ceca 24
CA - Canada 16
NL - Olanda 15
FR - Francia 11
ES - Italia 8
EU - Europa 7
IL - Israele 6
IQ - Iraq 6
AT - Austria 5
AU - Australia 5
MX - Messico 5
BD - Bangladesh 4
BE - Belgio 4
NZ - Nuova Zelanda 4
PL - Polonia 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
AR - Argentina 3
CH - Svizzera 3
CL - Cile 3
CR - Costa Rica 3
ID - Indonesia 3
JP - Giappone 3
PE - Perù 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
PH - Filippine 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
VE - Venezuela 1
Totale 12.158
Città #
Ann Arbor 2.160
Chandler 899
Jacksonville 751
Princeton 590
Woodbridge 540
Dong Ket 424
Wilmington 394
Houston 300
Singapore 241
Dublin 206
Nanjing 194
Ashburn 171
Izmir 170
Boardman 137
Andover 132
Beijing 131
Pellezzano 118
Munich 93
Salerno 80
Moscow 68
Hong Kong 64
Nanchang 55
Shenyang 55
Fairfield 54
Hebei 46
Jiaxing 44
Norwalk 42
Mestre 40
Changsha 35
Pune 29
Tianjin 27
Brno 23
Dallas 23
Naples 20
Dearborn 19
Düsseldorf 19
Helsinki 19
Jinan 19
Los Angeles 19
Shanghai 19
Turku 18
São Paulo 16
San Diego 15
Seattle 14
Washington 14
Amsterdam 13
Qualiano 12
Redwood City 12
San Francisco 12
The Dalles 12
West Jordan 12
Zhengzhou 12
Rome 11
Cambridge 10
Guangzhou 8
Stockholm 8
Bari 7
Brasília 7
Nuremberg 7
Nürnberg 7
Ottawa 7
Boston 6
Council Bluffs 6
Hangzhou 6
Lanzhou 6
Milan 6
Avellino 5
Falls Church 5
Indiana 5
New York 5
Phoenix 5
Porto Alegre 5
Santa Clara 5
Wuhan 5
Belo Horizonte 4
Brussels 4
Casagiove 4
Chengdu 4
Chennai 4
Curitiba 4
Duncan 4
Fisciano 4
Lappeenranta 4
Madrid 4
San Nicola la Strada 4
Sarno 4
Settimo Milanese 4
Tappahannock 4
Warsaw 4
Baghdad 3
Bologna 3
Campinas 3
Casalnuovo Di Napoli 3
Catania 3
Columbus 3
Ferrandina 3
Fuzhou 3
Haikou 3
Hefei 3
Kyiv 3
Totale 8.867
Nome #
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 239
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 168
Binding of the hemopressin peptide to the cannabinoid CB(1) receptor: structural insights. 150
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 145
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 139
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 136
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 133
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 126
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 125
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation 122
Structural Evidence ofN6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase 120
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 118
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 117
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 117
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 114
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 114
Applicazione degli inibitori della prenilazione nelle patologie proliferative della tiroide: la lovastatina induce apoptosi in cellule tiroidee umane. 113
The endocannabinoid signaling system in cancer 113
Dental care and dentistry practice in the Medieval Medical School of Salerno 113
Brain cancer risk: the weight of obesity 113
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 111
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 111
Cannabidiol: State of the art and new challenges for therapeutic applications 110
Thyroid adiponcosis: more than an hypothesis 109
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 109
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines 108
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. 107
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 106
Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. 106
Identification of CM223 as a new ligand of farnesyl pyrophosphate synthase with improved antiglioma action 102
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 101
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 101
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 101
Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells 99
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 99
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 95
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. 94
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 94
The right to care and the expectations of society?controversial stem cell therapy in Italy 94
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. 92
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A 92
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 89
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 89
Statins and cancer in gastroenterology: new insight? 89
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 89
Updates on Adiponcosis: More new incoming evidence strengthening the obesity-cancer link 89
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation 85
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 83
Statins and cancer-related mortality: an open question. 83
The basis of the modern medical hygiene in the medieval Medical School of Salerno 83
v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: multiple interference with the isoprenoid pathway 82
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 82
The HMG-CoA reductase inhibitor lovastatin induces apoptosis in proliferating human thyroid cells. 81
Statins in neurological disorders: an overview and update 81
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 80
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities 80
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 79
Cannabinoids and cancer: pros and cons of an antitumour strategy. 78
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. 78
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 78
A new role of anandamide in human sperm: focus on metabolism 77
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 76
Mediterranean diet: The missing link between gut microbiota and inflammatory diseases 76
End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion. 75
What we know and do not know about the cannabinoid receptor 2 (CB2) 75
A focus on Trotula de' Ruggiero: A pioneer in women's and children's health in history of medicine 75
Immuno-modulatory and anti-inflammatory effects of dihydrogracilin a, a terpene derived from the marine sponge Dendrilla membranosa 75
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 75
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. 74
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 74
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 74
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. 74
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 72
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 72
Breast adiponcosis: a call for further research 72
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. 72
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 71
Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency 70
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells 70
Cannabinoid receptor 1 antagonism in hepatocellular carcinoma: Killing two birds with one stone 69
Antibiotics exposure in obesity: an update of a complex relationship 69
The new task for medical scientists 69
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 67
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase. 67
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin 67
Trotula e le piante medicinali mediterranee: dal Medioevo alla cosmetologia moderna 66
The endocannabinoid system and its therapeutic exploitation. 66
Dietary and hypothyroid hypercholesterolemia induces hepatic apolipoprotein E expression in the rat: direct role of cholesterol. 66
Politics and Research: a desirable and essential dialogue 66
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 64
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation 64
Cannabinoid receptor CB1 antagonists state of the art and challenges 64
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. 64
Comment on 'When in Rome, reform'. 64
Concomitant BRAFV600E mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. 64
Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. 64
Statins for inflammatory bowel disease: Can off-label drug help it? 63
The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site. 63
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. 62
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 62
Totale 9.123
Categoria #
all - tutte 45.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.352 24 119 111 5 146 58 142 6 121 1 147 472
2021/20221.029 6 3 2 14 53 14 3 47 141 145 147 454
2022/20231.870 173 145 14 278 271 382 10 184 262 13 82 56
2023/2024670 68 105 42 30 48 114 14 28 8 35 49 129
2024/20251.870 116 27 106 99 79 184 310 170 269 70 204 236
2025/20263 3 0 0 0 0 0 0 0 0 0 0 0
Totale 12.464